Insider · SEDI
Zohar Krivorot
Zohar Krivorot has reported about $46.7M in shares of Cannara Biotech Inc on SEDI, Canada's insider filing system. That is #197 among the insiders we track.
Holdings as of November 17, 2026 · Director
Disclosed holdings
$46.7M
Companies
1
Buys / sells (12 months)
0 / 0
Net bought (12 months)
—
How to read insider buying
An insider buy is someone putting their own money where their mouth is, and insiders have the closest view of the business. Founders and CEOs buying their own company is common. The more telling pattern is an experienced investor holding stakes across several companies and adding over time: big buyers rarely stop at one purchase, so the first filings can put you early.
The Tuesday Stock Pick · free, every tuesday morning. One Canadian stock and the case for it.
Holdings by company
Latest balance reported on SEDI for each company (direct and through holding companies), valued at the latest close.
| Company | Role | Shares | Value | Last filing |
|---|---|---|---|---|
| Cannara Biotech IncLOVE.V · all insiders | Directorincl. indirect | 25,519,207 | $46.7M | 2026-02-11 |
Track record after buying
Every open-market buy since 2016, and what the stock did 3, 6 and 12 months later (adjusted closes; same-day buys of one stock count once; each return capped at +300%). Ranked #451 on the insider track record.
Buys
6
Avg after 3 months
+0.0%
Avg after 6 months
+0.0%
Avg after 12 months
−1.6%
Up after 1 year
0% of 6
| Date | Company | Bought | 3 mo | 6 mo | 12 mo |
|---|---|---|---|---|---|
| 2023-02-13 | Cannara Biotech IncLOVE.V | $20K | +0.0% | +0.0% | −4.2% |
| 2023-01-25 | Cannara Biotech IncLOVE.V | $21K | +0.0% | +0.0% | −5.3% |
| 2019-08-15 | Cannara Biotech IncLOVE.V | $19K | +0.0% | +0.0% | +0.0% |
| 2019-08-09 | Cannara Biotech IncLOVE.V | $62K | +0.0% | +0.0% | +0.0% |
| 2019-08-07 | Cannara Biotech IncLOVE.V | $47K | +0.0% | +0.0% | +0.0% |
| 2019-03-13 | Cannara Biotech IncLOVE.V | $238K | +0.0% | +0.0% | +0.0% |
Recent insider filings
| Date | Company | Type | Shares | Price | Balance after |
|---|---|---|---|---|---|
| 2026-02-11 | Cannara Biotech IncCommon Shares | Acquisition or disposition… | -333,333 | $2.10 | 1,260,225 |
| 2026-01-01 | Cannara Biotech IncRestricted Share Units (Common Shares) | Exercise of rights | -375,000 | — | 0 |
| 2026-01-01 | Cannara Biotech IncCommon Shares | Exercise of rights | 468,750 | — | 1,593,558 |
| 2025-02-10 | Cannara Biotech IncRestricted Share Units (Common Shares) | Exercise of rights | -749,808 | — | 375,000 |
| 2025-02-10 | Cannara Biotech IncCommon Shares | Exercise of rights | 749,808 | — | 1,124,808 |
| 2025-01-06 | Cannara Biotech IncRestricted Share Units (Common Shares) | Exercise of rights | -375,000 | — | 1,124,808 |
| 2025-01-06 | Cannara Biotech IncCommon Shares | Exercise of rights | 375,000 | — | 375,000 |
| 2024-11-22 | Cannara Biotech IncRestricted Share Units (Common Shares) | Grant of rights | 375,000 | — | 1,499,808 |
| 2023-12-06 | Cannara Biotech IncRestricted Share Units (Common Shares) | Grant of rights | 375,000 | — | 1,124,808 |
| 2023-02-13 | Cannara Biotech IncCommon Shares · via Javaa Private Equity Inc. | Buy | 1,500 | $0.900 | 24,258,982 |
| 2023-02-13 | Cannara Biotech IncCommon Shares · via Javaa Private Equity Inc. | Buy | 11,100 | $0.879 | 24,257,482 |
| 2023-02-13 | Cannara Biotech IncCommon Shares · via Javaa Private Equity Inc. | Buy | 9,600 | $0.883 | 24,246,382 |
| 2023-02-13 | Cannara Biotech IncCommon Shares · via Javaa Private Equity Inc. | Stock split or consolidation | -218,131,038 | — | 24,236,782 |
| 2023-02-10 | Cannara Biotech IncRestricted Share Units (Common Shares) | Grant of rights | 749,808 | — | 749,808 |
| 2023-01-25 | Cannara Biotech IncCommon Shares · via Javaa Private Equity Inc. | Buy | 200,000 | $0.105 | 242,367,820 |
| 2020-02-19 | Cannara Biotech IncCommon Shares · via Javaa Private Equity Inc. | Acquisition or disposition… | 8,161,626 | $0.091 | 242,167,820 |
| 2019-08-15 | Cannara Biotech IncCommon Shares · via Javaa Private Equity Inc. | Buy | 27,000 | $0.155 | 234,006,194 |
| 2019-08-15 | Cannara Biotech IncCommon Shares · via Javaa Private Equity Inc. | Buy | 98,000 | $0.150 | 233,979,194 |
| 2019-08-09 | Cannara Biotech IncCommon Shares · via Javaa Private Equity Inc. | Buy | 422,000 | $0.147 | 233,881,194 |
| 2019-08-07 | Cannara Biotech IncCommon Shares · via Javaa Private Equity Inc. | Buy | 345,000 | $0.137 | 233,459,194 |
| 2019-03-13 | Cannara Biotech IncCommon Shares · via Javaa Private Equity Inc. | Buy | 1,282,000 | $0.186 | 233,114,194 |
| 2018-12-31 | Cannara Biotech IncRestricted Share Units (Common Shares) | Opening Balance-Initial SE… | — | — | — |
| 2018-12-31 | Cannara Biotech IncOptions (Common Shares) | Opening Balance-Initial SE… | — | — | 6,000,001 |
| 2018-12-31 | Cannara Biotech IncCommon Shares · via Javaa Private Equity Inc. | Opening Balance-Initial SE… | — | — | 231,832,194 |
| 2018-12-31 | Cannara Biotech IncCommon Shares · via Javaa Private Equity Inc. | Opening Balance-Initial SE… | — | — | — |
| 2018-12-31 | Cannara Biotech IncCommon Shares · via Javaa Private Equity Inc. | Opening Balance-Initial SE… | — | — | — |
| 2018-12-31 | Cannara Biotech IncCommon Shares | Opening Balance-Initial SE… | — | — | — |
Free with a Wealth Awesome account
Keep analysing Zohar Krivorot, free
- Every WA Score, ranking and table
- Insider track records and SEDI filings
- Earnings history and analyst targets for every stock
Email only, no password, no card. Already a member? Use the same button to sign in.
How we count it: for each company we take the latest share balance Zohar Krivorot reported on SEDI for common-type shares (held directly or through holding companies) and value it at the latest close. Options, warrants and share units are left out, and so are balances with no filing in the last three years (insiders stop reporting when they leave the role). This is not a net worth figure: it covers only Canadian-listed shares reported on SEDI, and balances can lag until the next filing.
Canada's biggest insider shareholders · Latest insider trades
Awesome Portfolio™
Our 10 best Canadian stocks, in one list.
14.8% a year since 2017 against 9.7% for the S&P/TSX Composite (+5.0 points a year). Reviewed every month.